These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34216350)

  • 21. DNA damage induced by phenylalanine and its analogue p-chlorophenylalanine in blood and brain of rats subjected to a model of hyperphenylalaninemia.
    Simon KR; Dos Santos RM; Scaini G; Leffa DD; Damiani AP; Furlanetto CB; Machado JL; Cararo JH; Macan TP; Streck EL; Ferreira GC; Andrade VM; Schuck PF
    Biochem Cell Biol; 2013 Oct; 91(5):319-24. PubMed ID: 24032682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Blood Phenylalanine Levels on Oxidative Stress in Classical Phenylketonuric Patients.
    Kumru B; Kaplan DS; Oztürk Hismi B; Celik H
    Cell Mol Neurobiol; 2018 Jul; 38(5):1033-1038. PubMed ID: 29285660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolomics for improved treatment monitoring of phenylketonuria: urinary biomarkers for non-invasive assessment of dietary adherence and nutritional deficiencies.
    Wild J; Shanmuganathan M; Hayashi M; Potter M; Britz-McKibbin P
    Analyst; 2019 Nov; 144(22):6595-6608. PubMed ID: 31608347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidative damage in glutaric aciduria type I patients and the protective effects of l-carnitine treatment.
    Guerreiro G; Faverzani J; Jacques CED; Marchetti DP; Sitta A; de Moura Coelho D; Kayser A; Kok F; Athayde L; Manfredini V; Wajner M; Vargas CR
    J Cell Biochem; 2018 Dec; 119(12):10021-10032. PubMed ID: 30129250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidative stress in patients with phenylketonuria.
    Sirtori LR; Dutra-Filho CS; Fitarelli D; Sitta A; Haeser A; Barschak AG; Wajner M; Coelho DM; Llesuy S; Belló-Klein A; Giugliani R; Deon M; Vargas CR
    Biochim Biophys Acta; 2005 Apr; 1740(1):68-73. PubMed ID: 15878743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carnitine status in early-treated children, adolescents and young adults with phenylketonuria on low phenylalanine diets.
    Weigel C; Kiener C; Meier N; Schmid P; Rauh M; Rascher W; Knerr I
    Ann Nutr Metab; 2008; 53(2):91-5. PubMed ID: 18946205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of oxidative stress parameters in treated phenylketonuric patients.
    Sitta A; Barschak AG; Deon M; Terroso T; Pires R; Giugliani R; Dutra-Filho CS; Wajner M; Vargas CR
    Metab Brain Dis; 2006 Dec; 21(4):287-96. PubMed ID: 17146735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of DNA damage by L-carnitine induced by metabolites accumulated in maple syrup urine disease in human peripheral leukocytes in vitro.
    Mescka CP; Wayhs CA; Guerreiro G; Manfredini V; Dutra-Filho CS; Vargas CR
    Gene; 2014 Sep; 548(2):294-8. PubMed ID: 25046137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of phenylalanine and its metabolites on the proliferation and viability of neuronal and astroglial cells: possible relevance in maternal phenylketonuria.
    Oberdoerster J; Guizzetti M; Costa LG
    J Pharmacol Exp Ther; 2000 Oct; 295(1):295-301. PubMed ID: 10991993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood-brain phenylalanine relationships in persons with phenylketonuria.
    Koch R; Moats R; Guttler F; Guldberg P; Nelson M
    Pediatrics; 2000 Nov; 106(5):1093-6. PubMed ID: 11061780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. L-Carnitine supplementation decreases DNA damage in treated MSUD patients.
    Mescka CP; Guerreiro G; Hammerschmidt T; Faverzani J; de Moura Coelho D; Mandredini V; Wayhs CA; Wajner M; Dutra-Filho CS; Vargas CR
    Mutat Res; 2015 May; 775():43-7. PubMed ID: 25867118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered DNA methylation in PAH deficient phenylketonuria.
    Dobrowolski SF; Lyons-Weiler J; Spridik K; Biery A; Breck J; Vockley J; Yatsenko S; Sultana T
    Mol Genet Metab; 2015; 115(2-3):72-7. PubMed ID: 25990862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria.
    Pietz J; Kreis R; Rupp A; Mayatepek E; Rating D; Boesch C; Bremer HJ
    J Clin Invest; 1999 Apr; 103(8):1169-78. PubMed ID: 10207169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. White matter disturbances in phenylketonuria: Possible underlying mechanisms.
    Ferreira BK; Rodrigues MT; Streck EL; Ferreira GC; Schuck PF
    J Neurosci Res; 2021 Jan; 99(1):349-360. PubMed ID: 32141105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental hyperphenylalaninemia provokes oxidative stress in rat brain.
    Kienzle Hagen ME; Pederzolli CD; Sgaravatti AM; Bridi R; Wajner M; Wannmacher CM; Wyse AT; Dutra-Filho CS
    Biochim Biophys Acta; 2002 Apr; 1586(3):344-52. PubMed ID: 11997085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlations of blood and brain biochemistry in phenylketonuria: Results from the Pah-enu2 PKU mouse.
    Dijkstra AM; van Vliet N; van Vliet D; Romani C; Huijbregts SCJ; van der Goot E; Hovens IB; van der Zee EA; Kema IP; Heiner-Fokkema MR; van Spronsen FJ
    Mol Genet Metab; 2021 Nov; 134(3):250-256. PubMed ID: 34656426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenylpyruvic acid decreases glucose-6-phosphate dehydrogenase activity in rat brain.
    Rosa AP; Jacques CE; Moraes TB; Wannmacher CM; Dutra Ade M; Dutra-Filho CS
    Cell Mol Neurobiol; 2012 Oct; 32(7):1113-8. PubMed ID: 22477023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal serum phenylalanine for adult patients with phenylketonuria.
    Okano Y; Nagasaka H
    Mol Genet Metab; 2013 Dec; 110(4):424-30. PubMed ID: 24094552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-year retrospective analysis of patients with phenylketonuria (PKU) and hyperphenylalaninemia treated at two specialized clinics.
    Levy H; Lamppu D; Anastosoaie V; Baker JL; DiBona K; Hawthorne S; Lindenberger J; Kinch D; Seymour A; McIlduff M; Watling S; Vockley J
    Mol Genet Metab; 2020 Mar; 129(3):177-185. PubMed ID: 31883647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term dietary intervention with low Phe and/or a specific nutrient combination improve certain aspects of brain functioning in phenylketonuria (PKU).
    Bruinenberg VM; van Vliet D; van der Goot E; Counotte DS; Kuhn M; van Spronsen FJ; van der Zee EA
    PLoS One; 2019; 14(3):e0213391. PubMed ID: 30875376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.